Lawrence Kenyon - Chief Financial Officer, Director at Outlook Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Chief Financial Officer, Director
Issuer Symbol
OTLK on Nasdaq
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Lawrence Kenyon since 07 Feb 2025

Holdings reported by Lawrence Kenyon for Outlook Therapeutics, Inc.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 5,946 $33,828 $5.69 26 Sep 2024 Direct
Stock Option (Right to Buy) 12,500 20 Mar 2024 Direct Common Stock

Transactions reported by Lawrence Kenyon for Outlook Therapeutics, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.